Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition

Archives of Neurology

Volumn 53, Issue 5, 1996, Pages 418-422

  Corder, Elizabeth H ^a,b,c   Lannfelt, Lars ^b   Viitanen, Matti ^b,c   Corder, Larry S ^a   Manton, Kenneth G ^a   Winblad, Bengt ^b,c   Bosun, Hans ^b,c,d  

^a DUKE UNIVERSITY   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM GERONTOLOGY RESEARCH CENTER   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; ARTICLE; COGNITION; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; SURVIVAL;

EID: 0029886560     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550050048022     Document Type: Article

References (36)

1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science. 1988:240:622-630.
2. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E association with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin invest. 1985:82:1501-1513
3. Utermann G, Langenbeck U, Beisiegel U, Weber W Genetics of the apolipoprotein E system in man. Am J Hum Genet. 1980:32:339-347.
4. Schächter F, Faure-Detanef L, Guénot, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994,6 29-32.
5. Louhija J, Miettinen HE. Kontula K, Tikkanen MJ, Miettinen TA, Tilvis RS. Aging and genetic variation of plasma apolipoproteins. relative loss of the apolipoprotein E4 phenotype in centenarians. Artenoscter Thromb 1994;14 1084-1089.
6. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1-12.
7. Cauley JA, Eichner JE, Kamboh Ml, Ferrell RE, Kuller LH ApoE allele frequencies in younger (age 42-50) vs older (age 65-90) women Genet Epidemiol. 1993.10:27-34.
8. Eggertsen G, Tegelman R, Ericsson S, Angelin B1 Berglund L. Apolipoprotein E polymorphism in a healthy Swedish populati-on' variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993,39:2125-2129.
9. Sing CF, Moll PP Genetics of variability of CHD risk, lnt J Epidermol 1985; 18:S183-S195.
10. Pairitz-Jarvik G, Kukull WA Schellenberg GD, et al Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer disease in a case-control study Neurology. 1995,45.1092-1096.
11. Slrittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to beta-amyloid and increased frequency of type-4 allele in lateonset familial Alzheimer disease. Proc Natl Acad Sci U.S.A. 1993;90:1977-1981
12. Saunders AM, Strittmatter WJ, Schmechel DE, et al. Association of apolipoprotein E allele ε4 with late onset familial and sporadic Alzheimer's disease. Neurology. 1993:43:1467-1472.
13. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993:261:921-923.
14. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allete for late onset Alzheimer disease. Nat Genet. 1994;7:180-184.
15. Payami H,Kaye J, Heston LL, Bird Tu, Schellenberg GD. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 1993;342:738.
16. Borgaonkar DS, Schmidt LC, Martin SE, et al. Linkage of late-onset Alzheimer disease with apolipoprotein E type ε4 on chromosome 19 confirmed by family studies. Lancet. 1993;342:625.
17. Liddell M, Williams J, Bayer A, Kaiser F, Owen M Confirmation of association between the ε4 allele of apolipoprotein E and Alzheimer's disease. J Med Genet. 1994,31:197-200.
18. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ε4 allele in patients with Alzheimer's disease Ann Neurol. 1993;34:752-754.
19. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease allelic variation and receptor interactions Neuron 1993; 11:575-580.
20. Poirer J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E and Alzheimer's disease Lancet 1993;342:697-699.
21. Chartier-Harlin MC, Parfitt M. Legrain S, et al, Apolipoprotein E ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease analysis of the 19q13.2 chromosomal region Hum Mol Genet. 1994;14: 569-574.
22. Kuusisto J, Koivisto K, Kervinen K. et al Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ. 1994; 309:636-638.
23. Feskens EJM, Havekes LM, Kalmijn S, de Knijff P, Launer LJ, Kromhout D. Apolipoprotein ε4 allele and cognitive decline in elderly men. BMJ. 1994;309: 1202-1206
24. Reed T. Carmelli D, Swan GE, et al. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele. Arch Neurol. 1994;51 1189-1192
25. Fratiglioni L, Grut M, Forsell Y, et al. Prevalence of Alzheimer's disease in an elderly urban population' relationship with age, sex. and education. Neurology. 1991:41 1886-1892.
26. Fratiglioni L, Viitanen M, Backman L, Sandman P-O, Winblad B. Occurrence of dementia in advanced age: the study design of the Kungsholmen Project Neuroepidemiology 1992;1.29-36.
27. Folstein MF, Folstern SE, McHugh PR. Mini Mental State: a practical method for grading the cognitive state of patients for the clinician J Psychiatr Res. 1975:12:189-198.
28. Milter RG Nonparametric methods: regression. In Survival Analysis. New York, NY- John Wiley & Sons lnc; 1981:119-130.
29. The PHREG Procedure, Version 6. Gary, NC: SAS Institute, 1988. SAS Technical Report P-217.
30. Rao CR Large sample theory and methods In: Linear Statistical Inference and its Applications New York. NY: Wiley-Liss lnc; 1965:350-351.
31. Basun H, Grut M, Winblad B, Lannfelt L. Apolipoprotein ε4 allele and disease progression in patients with late-onset Atzheimer's disease. Neurosci Lett. 1995; 183:32-34
32. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer disease patients, and the competing risks of death and Alzheimer disease. Neurology. 1995,45.1323-1328.
33. The LIFETEST procedure. In Additional SAS/STAT Procedures, Version 6.03. Gary, NC. SAS Institute: 1988:49-89. SAS Technical Report P-179.
34. Lannfelt L, Lilius L, Nastase M, et al. Lack of association between apolipoprotein E allele ε4 and sporadic Alzheimer's disease. Neurosci Lett. 1994:169: 175-178.
35. Sobel E, Louhija J, Sulkava R, et al Lack of association of apolipoprotein E allele ε4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology 1995:45.903-907.
36. Rebeck GW, Perls TT, West HL. Sodhi P, Lipsitz LA, Hyman BT Reduced apoiipoprotein ε4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 1994;44.1513-1516.